X

Trial Profile

Candesartan antihypertensive survival evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 17 Jan 2017

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Candesartan cilexetil (Primary) ; Amlodipine
Indications Cardiovascular disorders; Hypertension
Focus Therapeutic Use
Acronyms CASE-J; CASE-J Ex

Most Recent Events

06 Sep 2013 Additional lead trial centres added as reported by University Hospital Medical Information Network - Japan record.
01 Dec 2011 Extension study results published in Hypertension Research.
29 Aug 2010 Effects of pre-existing type 2 diabetes and CHD on outcomes presented at the Annual Congress of the European Society of Cardiology (ESC) 2010 meeting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com